New data from Pfizer is indicating high efficacy for its COVID-19 vaccine as a booster, as well as its effectiveness among the 5-11 age group. The latter arrives in advance of next week’s discussion by the Food and Drug Administration over whether to authorize the vaccine for some pediatric patients. Data submitted for the Oct. 26 meeting of FDA’s Vaccines and Related Biological Products Advisory Committee indicate that Pfizer’s vaccine is nearly 91% effective at preventing symptomatic infections in children between the ages of 5 and 11. Additionally, the vaccine was well-tolerated.

Meanwhile, Pfizer yesterday released topline results from its Phase 3 clinical trial evaluating the safety and effectiveness of its booster in more than 10,000 people age 16 and older who initially received the two-dose vaccine. Pfizer said its data, which was culled while the delta variant was the dominant strain in the U.S., shows that the booster restored vaccine protection against COVID-19 to the high levels achieved after the second dose, showing a relative vaccine efficacy of 95.6% when compared to those who did not receive a booster.
 

Related News Articles

News
The U.S. District Court for the Eastern District of Missouri today granted a preliminary injunction preventing the Centers for Medicare & Medicaid Services…
Headline
A two-dose series of the Pfizer-BioNTech COVID-19 vaccine was 100% effective against COVID-19 in 12-15 year olds more than four months after the second dose in…
Headline
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., Friday expanded eligibility for COVID-19 booster shots to include all adults…
Headline
The Food and Drug Administration today authorized a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older at…
Headline
The federal government will purchase 10 million treatment courses of the COVID-19 oral antiviral Paxlovid from Pfizer if the Food and Drug Administration…
Headline
The Occupational Safety and Health Administration has suspended activities related to implementation and enforcement of its Emergency Temporary Standard on…